Millions Logo
home>stocks>Amrutanjan Health Care
Amrutanjan Health Care
Amrutanjan Health CareHealthcare
509.05-195.70 (-27.77%)in 1 year
as on 13 Oct 2026 at 15:29
Start SIP
52 Week Low: 476.5052 Week High: 760.15

Amrutanjan Health Care Share Price Today

Amrutanjan Health Care opened higher at ₹505.35, compared with its previous close of ₹501.65. During today's session, the stock has traded between ₹496.00 and ₹514.05, with an average traded price of ₹504.25. It is currently showing an upward intraday trend.

return calculator

Time Period

An investment of ₹10,000 made 5 years ago in Amrutanjan Health Care is now worth

₹ 6,129.00

resulting in a loss of

₹ 3,871.00 (38.71%)

invest now

Note: Past profits do not guarantee future returns.

Analyst Overview

No analyst rating data available.

Markets Today

Today's Change

+7.40 (+1.48%)

Day High

₹514.05

Day Low

₹496.00

Day Open

₹505.35

Prev Close

₹501.65

Volume

30,020

Value Traded

₹1.51 Cr

1W Return

-1.75%

1M Return

3.69%

3M Return

-5.42%

6M Return

-5.11%

1Y Return

-27.77%

Fundamentals

Market Cap (₹ Cr.)

1,472

PE Ratio

26.90

PB Ratio

3.93

Dividend Yield

0.98%

ROE

18.92%

ROCE

29.24%

Book Value (₹)

128.06

Face Value (₹)

1.00

EPS (TTM)

-

Industry PE

-

Beta

-

Debt to Equity

-

Investment Returns

1 Week

-1.75%

6 Week

-

1 Month

3.69%

3 Month

-5.42%

9 Month

-16.67%

Financials

Yearly
Consolidated
All values in ₹ crores
1.71

Mar 15
1.92

Mar 16

Share Holding Pattern

Promoter46.52%
FII2.44%
DII12.28%
Retails & Others32.06%

Updates

24Sep

Amrutanjan Health Care shareholders approve ₹2.90 per share dividend

Shareholders approved a final dividend of ₹2.90 per equity share for FY26. All four ordinary resolutions passed with over 99% votes in favour. Promoter group voted 99.92% of their shares, while public non-institutions voted 5.35%. Ramaa Prabhakar Arikirevula re-appointed as Non-Executive Director.

19 days ago
28Aug

Amrutanjan Health Care FY26 Results: PAT rises 14% to ₹57.92 crore

Amrutanjan Health Care reported FY26 PAT of ₹57.92 crore, up 13.93% YoY, on revenue from operations of ₹502.55 crore, up 11.23% YoY. EBITDA grew 14.82% to ₹66.83 crore with margin expanding to 13.30% from 12.88% in FY25. Pain management recorded 10% gross sales growth and Women's Hygiene brand Comfy posted 19% gross sales growth, with gross revenue reaching ₹151.31 crore. Quick Commerce channel grew 84.2% to ₹7.55 crore and Export revenue rose 36.1% to ₹11.15 crore in FY26. Board recommended a final dividend of ₹2.90 per share for FY26; total dividend for the year stands at ₹4.90 per share.

1mo ago
28Aug

Amrutanjan Health Care submits 89th annual report, sets AGM for Sep 23

Amrutanjan Health Care Limited filed its 89th Annual Report for FY26. The 89th AGM is scheduled for September 23, 2026, at 10:30 am. The meeting will be conducted via video conferencing or OAVM. Compliance follows SEBI LODR Regulations 34 and 36(1)(b).

1mo ago
5Aug

Amrutanjan Health Care commissions ₹150 cr Telangana sanitary napkin plant

Amrutanjan Health Care Limited has commissioned its fifth manufacturing plant in Seetharampur Village, Telangana, with a ₹150 crore investment. The facility produces 700 million sanitary napkins annually using automated Japanese technology and creates 350 jobs.

2mo ago
1Aug

Amrutanjan Health Care pays ₹9.75 Cr lease rent arrears per court order

Amrutanjan Health Care Limited paid ₹9,74,67,151 in lease rent arrears to Kapaleeswarar Temple on August 1, 2026, following a Madras High Court order. The court had dismissed the company's writ petition challenging the Tamil Nadu Hindu Religious and Charitable Endowment Act 1959. The company reported no significant operational impact from this settlement.

2mo ago
20Jun

Amrutanjan Health Care approves director appointments via postal ballot

Amrutanjan Health Care Limited shareholders approved the appointment of Dr. Ramaswami Krishnan and the re-appointment of Mr. Swayambunathan Muralidharan as Non-Executive Independent Directors for five-year terms through a remote e-voting process. The resolutions received 99.99% and 99.8% approval respectively, with Dr. Krishnan's tenure effective from May 8, 2026, to May 7, 2031, and Mr. Muralidharan's from June 29, 2026, to June 28, 2031.

3mo ago

Similar Stocks

StockLTPChange %Market Cap (Cr.)PE1Y Return
₹1,770.70+0.61%₹4,24,850.2434.83+5.97%
₹9,285.00-1.50%₹2,46,487.5885.12+43.41%
₹4,642.90-0.84%₹1,76,600.9982.55+31.42%
₹1,132.50-0.17%₹1,12,967.3124.74+14.00%
₹2,059.40-0.47%₹1,11,271.90102.63+134.89%
₹1,329.60+1.40%₹1,07,412.8631.62-14.87%
₹1,240.00+0.86%₹1,03,500.3632.26-1.93%
₹2,372.00-1.17%₹97,974.3047.92-3.57%
₹1,684.60-1.31%₹96,928.1626.40+49.04%
₹1,953.60+0.96%₹89,336.1716.03-0.29%
₹2,265.30-0.78%₹63,932.3535.82+16.81%
₹5,250.00+0.86%₹62,771.6328.34-3.75%